The Board of Directors of Aspinwall and Company Limited, in their meeting held on May 27, 2026, approved the audited standalone financial results for the quarter and year ended March 31, 2026. The company reported a standalone revenue of ₹12,852 lakhs for the quarter ended March 31, 2026, compared to ₹10,974 lakhs in the previous quarter and ₹8,741 lakhs in the corresponding quarter of the previous year. The standalone profit after tax stood at ₹683 lakhs for the quarter, against ₹710 lakhs in the previous quarter and ₹303 lakhs in the corresponding quarter of the previous year. The Board also recommended a first and final dividend of ₹6.50 per equity share for the financial year ended March 31, 2026.

Aspinwall and Company Limited is a multi-business enterprise incorporated in 1920, with interests spanning logistics, coffee, plantations, and other sectors. The company, headquartered in Thiruvananthapuram, has a heritage dating back to 1867 and operates through various subsidiaries, including SFS Pharma Logistics Private Limited and Aspinwall Healthcare Private Limited. The company’s diverse portfolio allows it to maintain a presence across multiple essential industries in India.